vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).
irinotecan hydrochloride injection, usp solution
generic medical partners inc - chlorhydrate d'irinotécan (chlorhydrate trihydraté d'irinotécan) - solution - 20mg - chlorhydrate d'irinotécan (chlorhydrate trihydraté d'irinotécan) 20mg - antineoplastic agents
irinotecan hydrochloride injection usp solution
accord healthcare inc - chlorhydrate d'irinotécan (chlorhydrate trihydraté d'irinotécan) - solution - 20mg - chlorhydrate d'irinotécan (chlorhydrate trihydraté d'irinotécan) 20mg - antineoplastic agents
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
apogo 10 mg/ml, solution injectable/pour perfusion
britannia pharmaceuticals limited - chlorhydrate d'apomorphine - solution - 10 mg - composition pour 1 ml > chlorhydrate d'apomorphine : 10 mg - agonistes dopaminergiques
codethylinehoude 5 mg, comprimé
sanofi aventis france - chlorhydrate d'éthylmorphine - comprimé - 5,000 mg - composition pour un comprimé > chlorhydrate d'éthylmorphine : 5,000 mg
debar adultes, sirop
société phoceal - chlorhydrate d'éthylmorphine - sirop - 0,110 g - composition pour 100 ml > chlorhydrate d'éthylmorphine : 0,110 g > benzoate de sodium : 1,750 g > grindélia (teinture de) : 3,300 g
dithiol adultes, sirop
laboratoire pharmaceutique galephar - chlorhydrate d'éthylmorphine - sirop - 0,10 g - composition pour 100 g de sirop > chlorhydrate d'éthylmorphine : 0,10 g
dithiol enfants, sirop
laboratoire pharmaceutique galephar - chlorhydrate d'éthylmorphine - sirop - 0,04 g - composition pour 100 g de sirop > chlorhydrate d'éthylmorphine : 0,04 g
pecto-broncol adultes, sirop
société phoceal - chlorhydrate d'éthylmorphine - sirop - 0,110 g - composition pour 100 ml > chlorhydrate d'éthylmorphine : 0,110 g > benzoate de sodium : 1,750 g > grindélia (teinture de) : 3,300 g